NCT01918527View on ClinicalTrials.gov

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2025

Conditions
Colon Cancer
Interventions
DRUG

Capecitabine

Orally on days 1-14: 2000 mg/m2/day q3w

DRUG

Oxaliplatin

Intravenously on day 1: 130 mg/m2 q3w

Trial Locations (9)

Unknown

Aalborg University Hospital, Aalborg

Rigshospitalet, Copenhagen

Herlev Hospital, Herlev

Hilleroed Hospital, Hillerød

Roskilde Hospital, Roskilde

Sygehus Sønderjylland, Sønderborg

Vejle Hospital, Vejle

Haukeland University Hospital, Bergen

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Vejle Hospital

OTHER